Evidence map›Paper›PMID 25701738›Full record

ArticleGastroenterology2015

Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.

Hiroyuki Tsuchiya, Kerry-Ann da Costa, Sangmin Lee, Barbara Renga, Hartmut Jaeschke, Zhihong Yang, Stephen J Orena, Michael J Goedken, Yuxia Zhang, Bo Kong and 7 more

Abstract read
In one paragraph

Article in Gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Hepatocyte miR-21-5p-deficiency alleviates APAP-induced liver injury by inducing PPARγ and autophagy.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Emerging role of circadian clock disruption in alcohol-induced liver disease.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Hiroyuki TsuchiyaDepartment of Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Kerry-Ann da CostaNutrition Research Institute, Department of Nutrition, University of North Carolina at Chapel Hill, North Carolina.
Sangmin LeeDepartment of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut.
Barbara RengaDipartimento di Scienze Chirurgiche e Biomediche, University of Perugia, Perugia, Italy.
Hartmut JaeschkeDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Zhihong YangDepartment of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.
Stephen J OrenaNutrition Research Institute, Department of Nutrition, University of North Carolina at Chapel Hill, North Carolina.
Michael J GoedkenTranslational Sciences, Rutgers University, Piscataway, New Jersey.
Yuxia ZhangDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Bo KongDepartment of Pharmacology and Toxicology of School of Pharmacy, Rutgers University, Piscataway, New Jersey.
Margitta LebofskyDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Swetha RudraiahDepartment of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut.
Rana SmallingDepartment of Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Grace GuoDepartment of Pharmacology and Toxicology of School of Pharmacy, Rutgers University, Piscataway, New Jersey.
Stefano FiorucciDipartimento di Scienze Chirurgiche e Biomediche, University of Perugia, Perugia, Italy.
Steven H ZeiselNutrition Research Institute, Department of Nutrition, University of North Carolina at Chapel Hill, North Carolina.
Li WangDepartment of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; Department of Internal Medicine, Section of Digestive Diseases, Yale University, New Haven, Connecticut. Electronic address: li.wang@uconn.edu.
Rutgers, The State University of New Jersey · USUniversity of Connecticut · USUniversity of Kansas Medical Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Perugia · ITUniversity of Utah · USVA Connecticut Healthcare System · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MA, XIAOCHAO · 2006 to 2011
$12.1M
SHP-regulation of Lipid and Lipoprotein MetabolismR01DK080440 · NIDDK · UNIVERSITY OF UTAH · PI WANG, LI · 2008 to 2015
$2.3M
LncRNA as a New Mediator of Bile Acid HomeostasisR01DK104656 · NIDDK · UNIVERSITY OF CONNECTICUT STORRS · PI WANG, LI · 2015 to 2018
$1.7M
Metabolic reprogramming in liver cancer cells by a novel tumor suppressorK22CA184146 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ZHANG, YUXIA · 2014 to 2016
$303k
Circadian Clock Regulation of Alcoholic Liver DiseaseI01BX002634 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI WANG, LI · 2016 to 2019
–
BLRD VA I01 BX002634NCI NIH HHS K22 CA184146NCI NIH HHS K22CA184146NCI NIH HHS P30 CA042014NCRR NIH HHS P20 RR021940NIDDK NIH HHS 5 P30 DK020579NIDDK NIH HHS DK056350NIDDK NIH HHS DK080440NIDDK NIH HHS DK104656NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056350NIDDK NIH HHS R01 DK080440NIDDK NIH HHS R01 DK104656
6 · The paper itself

Abstract

BACKGROUND &

aimsHyperhomocysteinemia is often associated with liver and metabolic diseases. We studied nuclear receptors that mediate oscillatory control of homocysteine homeostasis in mice.

methodsWe studied mice with disruptions in Nr0b2 (called small heterodimer partner [SHP]-null mice), betaine-homocysteine S-methyltransferase (Bhmt), or both genes (BHMT-null/SHP-null mice), along with mice with wild-type copies of these genes (controls). Hyperhomocysteinemia was induced by feeding mice alcohol (National Institute on Alcohol Abuse and Alcoholism binge model) or chow diets along with water containing 0.18% DL-homocysteine. Some mice were placed on diets containing cholic acid (1%) or cholestyramine (2%) or high-fat diets (60%). Serum and livers were collected during a 24-hour light-dark cycle and analyzed by RNA-seq, metabolomic, and quantitative polymerase chain reaction, immunoblot, and chromatin immunoprecipitation assays.

resultsSHP-null mice had altered timing in expression of genes that regulate homocysteine metabolism compared with control mice. Oscillatory production of S-adenosylmethionine, betaine, choline, phosphocholine, glyceophosphocholine, cystathionine, cysteine, hydrogen sulfide, glutathione disulfide, and glutathione, differed between SHP-null mice and control mice. SHP inhibited transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1. Expression of Bhmt and cystathionine γ-lyase was decreased when mice were fed cholic acid but increased when they were placed on diets containing cholestyramine or high-fat content. Diets containing ethanol or homocysteine induced hyperhomocysteinemia and glucose intolerance in control, but not SHP-null, mice. In BHMT-null and BHMT-null/SHP-null mice fed a control liquid, lipid vacuoles were observed in livers. Ethanol feeding induced accumulation of macrovesicular lipid vacuoles to the greatest extent in BHMT-null and BHMT-null/SHP-null mice.

conclusionsDisruption of Shp in mice alters timing of expression of genes that regulate homocysteine metabolism and the liver responses to ethanol and homocysteine. SHP inhibits the transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1.

Indexed as

Circadian RhythmAnimalsBetaine-Homocysteine S-MethyltransferaseBlood GlucoseCholestyramine ResinCholic AcidCystathionine gamma-LyaseDiet, High-FatDisease Models, AnimalEthanolGene Expression Regulation, EnzymologicGlucose IntoleranceHepatocyte Nuclear Factor 3-alphaHomeostasisHomocysteineHyperhomocysteinemiaBetaine-Homocysteine S-MethyltransferaseBhmt protein, mouseBlood GlucoseCholestyramine ResinCholic AcidCystathionine gamma-LyaseEthanolFoxa1 protein, mouseHepatocyte Nuclear Factor 3-alphaHomocysteinenuclear receptor subfamily 0, group B, member 2Receptors, Cytoplasmic and NuclearRNA, MessengerCircadian RegulationLiver Disease ModelMetabolismNuclear Receptor

Identifiers

PMID25701738
PMCPMC4409521
OpenAlexW2115390339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.